156 related articles for article (PubMed ID: 37573687)
1. Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors.
Ding J; Zheng Y; Zhu F; Wang M; Fang L; Li H; Tian H; Liu Y; Wang G; Zheng J; Chai D
Int Immunopharmacol; 2023 Oct; 123():110722. PubMed ID: 37573687
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus vaccine therapy with CD137L promotes CD8
Ding J; Jiang N; Zheng Y; Wang J; Fang L; Li H; Yang J; Hu A; Xiao P; Zhang Q; Chai D; Zheng J; Wang G
Pharmacol Res; 2022 Jan; 175():106034. PubMed ID: 34915126
[TBL] [Abstract][Full Text] [Related]
3. Co-immunization with L-Myc enhances CD8
Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
[TBL] [Abstract][Full Text] [Related]
4. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
5. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.
Zhang SN; Choi IK; Huang JH; Yoo JY; Choi KJ; Yun CO
Mol Ther; 2011 Aug; 19(8):1558-68. PubMed ID: 21468000
[TBL] [Abstract][Full Text] [Related]
6. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
[TBL] [Abstract][Full Text] [Related]
7. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
[TBL] [Abstract][Full Text] [Related]
8. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
[TBL] [Abstract][Full Text] [Related]
9. Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8
Chai D; Shan H; Wang G; Zhang Q; Li H; Fang L; Song J; Liu N; Zhang Q; Yao H; Zheng J
Mol Cancer Ther; 2019 Feb; 18(2):323-334. PubMed ID: 30401695
[TBL] [Abstract][Full Text] [Related]
10. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro.
Cui H; Zhang W; Hu W; Liu K; Wang T; Ma N; Liu X; Liu Y; Jiang Y
PLoS One; 2013; 8(5):e63055. PubMed ID: 23650543
[TBL] [Abstract][Full Text] [Related]
11. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
Okada N; Iiyama S; Okada Y; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
Cancer Gene Ther; 2005 Jan; 12(1):72-83. PubMed ID: 15389286
[TBL] [Abstract][Full Text] [Related]
12. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
13. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
[TBL] [Abstract][Full Text] [Related]
14. CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8
Dharmadhikari B; Nickles E; Harfuddin Z; Ishak NDB; Zeng Q; Bertoletti A; Schwarz H
Cancer Immunol Immunother; 2018 Jun; 67(6):893-905. PubMed ID: 29508025
[TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
16. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
Liang W; Wang XF
Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
[TBL] [Abstract][Full Text] [Related]
17. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
18. Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.
Wan Y; Emtage P; Zhu Q; Foley R; Pilon A; Roberts B; Gauldie J
Cell Immunol; 1999 Dec; 198(2):131-8. PubMed ID: 10648127
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.
Broder H; Anderson A; Odesa SK; Kremen TJ; Liau LM
Neurosurg Focus; 2000 Dec; 9(6):e6. PubMed ID: 16817689
[TBL] [Abstract][Full Text] [Related]
20. Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity.
Chai D; Qiu D; Shi X; Ding J; Jiang N; Zhang Z; Wang J; Yang J; Xiao P; Wang G; Zheng J
Mol Ther Oncolytics; 2022 Mar; 24():1-13. PubMed ID: 34977338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
